Browse Obstetrics/Gynecology Topics Articles by Topic

Is Cannabis Abuse During Pregnancy Associated with Poor Neonatal Outcomes?

Cannabis use disorder is associated with small but significant increased risks measured in multiple neonatal outcomes.

Permanent Contraception Regret in the Modern Age

In this Canadian cross-sectional survey of a convenience sample of 844 patients who had undergone female sterilization, the prevalence of regret was 16%.

Pelvic Exams During Annual Gynecologic Visits

A retrospective chart review of 1,121 patients undergoing annual gynecology exams showed that 1.2% (95% confidence interval [CI], 0.5 to 1.9) of asymptomatic patients had physical exam findings on pelvic exam compared to 32.4% (95% CI, 27.0 to 37.8) of symptomatic patients.

Integrating Reproductive History Could Help Postmenopausal Women’s Long-Term Brain Health

Researchers observed patients with higher cumulative estrogen exposure throughout their life may be at lower risk of developing cerebral small vessel disease.

Nonhormonal Treatment for Menopausal Vasomotor Symptoms: A Phase III Study of Fezolinetant

More than 500 women with moderate to severe menopausal vasomotor symptoms received either 45 mg of fezolinetant, 30 mg fezolinetant, or placebo. Both fezolinetant doses significantly reduced the frequency and severity of menopausal symptoms at four and 12 weeks of treatment vs. placebo.

Zuranolone Capsules (Zurzuvae)

Zuranolone can be prescribed to treat postpartum depression.

Postpartum Depression Medication Headed to Market

FDA approves first oral solution.

Fezolinetant Tablets (Veozah)

Fezolinetant can be prescribed to treat moderate-to-severe vasomotor symptoms caused by menopause.

Oral Medication to Treat ‘Hot Flashes’ Could Be Available Soon

The FDA has approved the first neurokinin 3 receptor antagonist to alleviate symptoms associated with moderate to severe vasomotor symptoms caused by menopause.

Does Topiramate Decrease the Efficacy of Oral Contraceptives?

Women taking low-dose topiramate (< 200 mg per day) and oral contraception did not experience more contraceptive failures compared to women taking other headache remedies (propranolol, metoprolol, amitriptyline, venlafaxine, or verapamil).